Buscar
« Anterior |
1 - 50 de 68
|
Siguiente »
Resultados de la búsqueda
Select an image to start the slideshow
Longitudinal trends in glycated hemoglobin among individuals with latent TB infection in Addis Ababa, Ethiopia
1 of 50
Tuberculosis Preventive Therapy Uptake Among Adults Living with HIV in Zimbabwe: Analyzing Zimbabwe Population-Based HIV Impact Assessment (ZIMPHIA) 2020 and 2015-16
2 of 50
Clinical markers of severe TB disease in the United States before and after the onset of the COVID-19 pandemic, 2010–2020
3 of 50
Whole Blood Mycobacterial Growth Assays And Tuberculosis Susceptibility
4 of 50
Detection of TB Infection among Indian Infants Using Non-Interferon Gamma Cytokines
5 of 50
A Genome-Wide Association Study of Resistance to Tuberculosis Infection in a Multi-Ancestry Brazilian Cohort
6 of 50
Association between changes in body mass index and self-reported quality of life among patients successfully treated for tuberculosis disease in Tbilisi, Georgia
7 of 50
The Association of Substance Use and Depression Among TB Infected Persons Incarcerated in Haitian Prisons
8 of 50
The impact of diabetes and pre-diabetes on prevalence of Mycobacterium tuberculosis infection among household contacts of active tuberculosis cases in Ethiopia
9 of 50
Dissecting Mycobacterium tuberculosis immune evasion of dendritic cell-T cell crosstalk
10 of 50
Epidemiology of tuberculosis and hepatitis C virus (HCV) coinfection in the country of Georgia
11 of 50
Treatment Outcomes of Pulmonary Tuberculosis at Population Services International Clinic Networks, Myanmar: A Retrospective Cohort Study from 2012-2016
12 of 50
New strategies for an old disease: the social barriers to targeted testing and treatment of latent tuberculosis infection
13 of 50
Inference of Inter-Individual Heterogeneity in Tuberculosis Transmission
14 of 50
Distribution and Determinants of Tuberculosis among Non-Saudi Residents, Kingdom of Saudi Arabia, 2018
15 of 50
NK cell immunity in Mycobacterium tuberculosis and HIV infection
16 of 50
Video Directly Observed Therapy for TB Treatment in Haitian Correctional Facilities
17 of 50
Presentation and Treatment Outcomes by Diabetes Status among Patients with Tuberculosis in Guam, 2015–2018
18 of 50
T cell immunity during co-infection with Mycobacterium tuberculosis and Schistosoma mansoni
19 of 50
CD4 T Cell Responses in Mycobacterium tuberculosis and HIV Co-infection
20 of 50
Diagnosis and Prevention of Active TB Disease
21 of 50
Incidence and Prediction of Symptoms and Drug Sensitivity Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) for Treatment of Latent Tuberculosis Infection
22 of 50
Influence of HIV Co-infection on Tuberculosis Treatment Outcomes in Children: A Systematic Review and Meta-analysis of the Literature
23 of 50
Delays to TB care among Zambian mineworkers: Application of the Three-Delay Framework
24 of 50
A county-level, ecologic analysis of correlations between recent tuberculosis transmission and socioeconomic indicators of poverty.
25 of 50
HIV and Tuberculosis in Atlanta, GA: Antiretroviral Therapy Uptake
and Factors Associated with Unfavorable Outcomes
26 of 50
Survival Analysis Comparing HIV Infection Status and Time until
Diagnosis in Tuberculosis Cases in the United States Foreign-Born
Population by Region of Origin, 2005-2015
27 of 50
Impact of Mobile Teams on Tuberculosis Treatment Outcomes,
Ministry of Health, Riyadh Region, Kingdom of Saudi Arabia, 2013 -
2015
28 of 50
Tumor Necrosis Factor-Antagonist Therapy Exposure Associated with
Sputum Conversion by Eight Weeks among United States Tuberculosis
Patients, 2010-2015
29 of 50
Prevalence and Risk Factors of TB Disease in South African
Correctional Facilities
30 of 50
Impact of Active Case-Finding on Tuberculosis Transmission Among
the Homeless in Fulton County, Georgia, 2010-2015: Secondary Data
Analysis
31 of 50
Cost Savings Associated with Implementation of the MTBDRplus
Assay in the Republic of Georgia
32 of 50
Characterization of tuberculosis (TB) in Lebanon: epidemiology and
risk factors for extrapulmonary TB
33 of 50
Tuberculosis Screening Among Immigrants Entering the United States:
An Analysis of Radiographic Findings of China, Mexico, Nepal,
Philippines and Vietnam
34 of 50
Cox Proportional Hazards Analysis to
Determine the Predictors of Time-to-Sputum Culture Conversion in
Patients with Tuberculosis
35 of 50
Influences of the Homeless Shelter Environment on the
Personal Experience of Tuberculosis Disease During a Large Outbreak
in Atlanta, Georgia
36 of 50
Plasma Metabolomics in the Diagnosis of Pulmonary Tuberculosis and
Early Identification of Multidrug Resistance
37 of 50
Examination of Optimal Culture Methodologies and Conditions for
Tuberculosis Treatment Trials
38 of 50
Evaluation of Tuberculosis Public Health Surveillance,Al-Madinah Province, Kingdom of Saudi Arabia, 2012
39 of 50
Does Level of Access to Tuberculosis (TB) Treatment Predict Default
Patterns? A multilevel analysis.
40 of 50
Multi-drug Resistant (MDR) and Extensively Drug Resistant (XDR)
Tuberculosis Case Study Book Project
41 of 50
THE OCCURRENCE OF CLINICALLY ACTIVE TUBERCULOSIS AMONG HIV-INFECTED
PERSONS IN MUMBAI, INDIA.
42 of 50
Agreement between Tuberculin Skin Test (TST) and QuantiFERON-TB
Gold In-Tube (QFT) Assay When Screening for Latent Tuberculosis
Infection (LTBI) in Young Refugee Children
43 of 50
Diabetes mellitus and active tuberculosis disease: Clinical
presentation and treatment outcomes in adult tuberculosis patients
44 of 50
A Comparative Analysis in the Annual Rate of Change in US-born
Non-Hispanic Black and US-born Non-Hispanic White Tuberculosis
Cases, 1993-2011
45 of 50
Change in Chest Radiography and Examination of Clinical Features to
Identify Pulmonary Tuberculosis in a Haitian Prison
46 of 50
Risk factors for active and latent tuberculosis (TB) among contacts
of smear-positive index TB patients in the country of Georgia
47 of 50
Tuberculosis Prevalence Among Entrants and Stock Population in a
Haitian Prison: A Quality Assessment of Screening Procedures
48 of 50
The Role of Exogenous Reinfection in Patients with Recurrent TB
Disease in the United States
49 of 50
Utilizing genotypic mutations to determine treatment effectiveness among MDR and XDR TB patients in KwaZulu-Natal, SouthAfrica
50 of 50